CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.
CD8 T 细胞可以弥补 COVID-19 血液肿瘤患者体液免疫受损的情况
期刊:
影响因子:
doi:10.21203/rs.3.rs-162289/v1
Bange Erin M, Han Nicholas A, Wileyto Paul, Kim Justin Y, Gouma Sigrid, Robinson James, Greenplate Allison R, Porterfield Florence, Owoyemi Olutosin, Naik Karan, Zheng Cathy, Galantino Michael, Weisman Ariel R, Ittner Caroline A G, Kugler Emily M, Baxter Amy E, Oniyide Olutwatosin, Agyekum Roseline S, Dunn Thomas G, Jones Tiffanie K, Giannini Heather M, Weirick Madison E, McAllister Christopher M, Babady N Esther, Kumar Anita, Widman Adam J, DeWolf Susan, Boutemine Sawsan R, Roberts Charlotte, Budzik Krista R, Tollett Susan, Wright Carla, Perloff Tara, Sun Lova, Mathew Divij, Giles Josephine R, Oldridge Derek A, Wu Jennifer E, Alanio Cécile, Adamski Sharon, Garfall Alfred L, Vella Laura, Kerr Samuel J, Cohen Justine V, Oyer Randall A, Massa Ryan, Maillard Ivan P, Maxwell Kara N, Reilly John P, Maslak Peter G, Vonderheide Robert H, Wolchok Jedd D, Hensley Scott E, Wherry E John, Meyer Nuala, DeMichele Angela M, Vardhana Santosha A, Mamtani Ronac, Huang Alexander C
